Viewing Study NCT00130260


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2025-12-26 @ 7:14 PM
Study NCT ID: NCT00130260
Status: TERMINATED
Last Update Posted: 2008-01-04
First Post: 2005-08-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of a Third and Fourth Dose of StaphVAX® in Adults With End-Stage Renal Disease
Sponsor: Nabi Biopharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-08
Start Date Type: None
Primary Completion Date: 2005-12
Primary Completion Date Type: ACTUAL
Completion Date: 2006-04
Completion Date Type: ACTUAL
First Submit Date: 2005-08-12
First Submit QC Date: None
Study First Post Date: 2005-08-15
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2007-12-26
Last Update Post Date: 2008-01-04
Last Update Post Date Type: ESTIMATED